Author(s):
Keyur S. Patel, Kinjal R. Baria, Deepa R. Patel, Kunal N. Patel
Email(s):
keyurpatel.pharmacy@gmail.com
DOI:
10.52711/0974-360X.2025.00450
Address:
Keyur S. Patel1*, Kinjal R. Baria2, Deepa R. Patel2, Kunal N. Patel1
1Department of Pharmaceutics, K. B. Raval College of Pharmacy, Shertha, Gandhinagar - 382423 Gujarat, India.
2Kalol Institute of Pharmacy, Kalol, Gandhinagar - 382721, Gujarat, India.
*Corresponding Author
Published In:
Volume - 18,
Issue - 7,
Year - 2025
ABSTRACT:
The objective of the work was to formulate and evaluate gastroretentive in situ gel of captopril to reduce dosing frequency by prolonged gastric retention. Gastroretentive in situ gel of captopril was formulated by ion gelation method. A 32 full factorial design was applied to study the effect of different concentration gellan gum and HPMC K4M on % drug release at 6 h, viscosity and floating lag time. All batches were evaluated for various parameters like pH, gelling capacity, gelling time, floating lag time, floating time, viscosity, drug release and stability study. Optimized formulation shows in vitro drug release of 67.09±1.9 in 6 h and 100.46±1.1 in 12 h, viscosity 165±1.03 cp and floating lag time 24±0.9 sec. From all the evaluation parameter and experimental design, it was concluded that the drug release rate decreases with increase in concentration of gellan gum and HPMC K4M. Floating lag time and viscosity increases with increase in concentration of gellan gum and HPMC K4M.The in vitro drug release kinetic revealed that the Higuchi model is followed and drug release is by fickian diffusion.
Cite this article:
Keyur S. Patel, Kinjal R. Baria, Deepa R. Patel, Kunal N. Patel. Formulation and Evaluation of Gastroretentive In situ Gel of Captopril. Research Journal of Pharmacy and Technology. 2025;18(7):3133-8. doi: 10.52711/0974-360X.2025.00450
Cite(Electronic):
Keyur S. Patel, Kinjal R. Baria, Deepa R. Patel, Kunal N. Patel. Formulation and Evaluation of Gastroretentive In situ Gel of Captopril. Research Journal of Pharmacy and Technology. 2025;18(7):3133-8. doi: 10.52711/0974-360X.2025.00450 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-7-30
REFERENCES:
1. Satinderkakar. Singh R. Shallu S. Gastroretentive drug delivery system: A review. African Journal of Pharmacy and Pharmacology. 2015; 9(12): 415-7. doi.org/10.5897/AJPP2015.4307
2. Sarika S. Kunjwani HK. Kawade J. Novel polymeric in-situ gels for ophthalmic drug delivery system. International Journal of Research in Pharmacy and Science. 2012; 2(1): 67-83.
3. Jorapur D. Nagesh C. Suma N. Chandrasekhara S, Attimarad SL, Kengeri S. Ion Sensitive Floating in Situ Gel for Controlled Delivery of Famotidine and Domperidone Maleate for the Treatment of Gastro Oesophageal Reflux Disease. Research J. Pharm. and Tech. 2018; 11(5): 1984-1989. DOI: 10.5958/0974-360X.2018.00369.4
4. Bhardwaj L. Sharma PK. Malviya R. A short review on gastro retentive formulation for stomach specific drug delivery: specialemphasis on floating in situ gel systems. African Journal of Basic and Applied Sciences. 2011; 3(6): 300-312.
5. Patel RB. Chauhan MA. Shah AL. Suthar SJ. Patel MP. Patel JK. Floating In Situ Gel: New Trends in Controlled and Sustained Gastroretentive Drug Delivery System. Research J. Pharm. and Tech. 2012; 5(7): 889-893.
6. Bhagyashri VA. Chaudhari BP. Velhal AB. Redasani VK. A review on in situ gel of gastro retentive drug delivery system. Asian Journal of Research in Pharmaceutical Sciences. 2022; 12(4): 314-0. DOI:10.52711/2231-5659.2022.00054
7. Gudad A. Formulation and evaluation of floating microspheres of captopril for prolonged resident time. Indian Journal of Novel Drug Delivery. 2017; 3(1): 17-23.
8. Bukka R. Patel N. Nargund LVG. Prakasam K. Formulation and evaluation of coated floating tablets of captopril. Research Journal of Pharmacy and Technology. 2012; 5(7): 992-996.
9. Bahadur S. Chanda R. Roy A. Choudhury A. Das S. Saha S. Preparation and evaluation of mucoadhesive microcapsules of captopril for oral controlled release. Research J. Pharm. and Tech. 2008; 1(2): 100-105.
10. Chandra MS. Tiwari DK. Ingale SJ. Singhai AK. Formulation and physicochemical evaluation of floating tablets of captopril. Research J. Pharm. and Tech. 2011; 4(8): 1292-1296.
11. Bhilegaonkar SP. Volvoikar SG. Naik AG. Formulation and evaluation of bilayer gastric mucoadhesive patch of captopril. Research J. Pharm. and Tech. 2018; 11(6): 2444-2453. DOI: 10.5958/0974-360X.2018.00451.1
12. Pagar UN. Surawase RK. Formulation and evaluation of captopril sustained release pellet containing tablet by fluidized bed processing. Research Journal of Pharmaceutical Dosage Forms and Technology. 2022; 14(1): 33-8. DOI: 10.52711/0975-4377.2022.00006
13. Chaudhari UR. Review of captopril drug formulation, mechanism of action, dosage, use and adverse drug reactions. Research Journal of Pharmaceutical Dosage Forms and Technology. 2021; 13(2): 157-0 DOI: 10.52711/0975-4377.2021.00028
14. Patel P. Dand N. Hirlekar RS. Design and evaluation of a sustained release gastroretentive dosage form of captopril: A technical note. AAPS Pharma Sci Tech. 2008; 9(3): 836-839.
15. Karemore MN. Avari JG. Insitu Gel of Nifedipine for preeclampsia: Optimization, In vitro and in vivo evaluation. Journal of Drug Delivery Science and Technology. 2019; 50: 78-89. DOI: 10.1208/s12249-019-1391-2
16. Mishra. Floating in situ gelling system for stomach site specific delivery of clarithromycin to eradicate H. pylori. J cont Rel. 2008; 125(1): 34-41. DOI: 10.1016/j.jconrel.2007.07.011
17. Rao MR. Shelar SU. Controlled release ion sensitive floating oral in situ gel of prokinetic drug using gellan gum. Indian Journal of Pharmaceutical Education and Research. 2015; 49(2): 158-167. DOI: 10.5530/ijper.49.2.13
18. Chaniyara S. Modi D. Patel R. Formulation and evaluation of floating in situ gel for stomach specific drug delivery of Ofloxacin. American Journal of Advanced Drug Delivery. 2013; 1(3): 285-299.
19. Remya PN. Gayatri H. Saraswathi TS. Kavitha R. Damodharan N. Development and evaluation of floating in situ gel solution of lansoprazole. Research Journal of Pharmacy and Technology. 2017; 10(12): 4323-4327. DOI: 10.5958/0974-360X.2017.00792.2
20. Asmaa HE. Ramadan AA. Asmaa ME. Development and characterization of in situ gel containing lefunomide as a gastro retentive drug delivery.Int. J. Pharm. Sci.Rev. Res. 2020; 64(2): 8-16. DOI: 10.47583/ijpsrr.2020.v64i02.002
21. Haoping Xu. Min S. Tao MA. Novel in situ gel formulation of ranitidine for oral sustained delivery Biomolecule and therapeutic 2014;22(2):161-165. DOI: 10.4062/biomolther.2013.109
22. Bobade NN. Pande SS. Formulation and evaluation of controlled release gastroretentive in situ gel for Diltiazem HCL.International Journal of Pharmaceutics and Research. 2016; 50(3): 254-264. DOI: 10.5530/ijper.50.3.36
23. Singh SR. Jadhav KR. Novel floating in situ gel of antihyperlipidemic agent. Research Journal of Pharmacy and Technology. 2019; 12(3): 1086-1090. DOI: 10.5958/0974-360X.2019.00178.1
24. Pandey A. Jagde S Japta J. In situ gelling gellan formulation as vehicle for oral sustained delivery of Famotidin. Inventi: Rapid NDDS, 2012(3).
25. Miyazaki S. Aoyanta H. Kawasaki N. In situ gelling gellan formulation as vehicle for oral delivery.J. Cont Rel. 1999; 67(2): 275-80. doi: 10.1016/s0168-3659(99)00084-x.
26. Patel RP. Dadhani B., Ladani R. Formulation, evaluation and optimization of stomach specific in situ gel of clarithromycin and metronidazole benzoate. Int J Drug Del. 2010; 2(2): 141-53. DOI:10.5138/ijdd.2010.0975.0215.02023